Thiotepa
CAS 52-24-4 13 FDA-DMF suppliersSmall Molecule
Overview
Thiotepa is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL671).
API suppliers (12)
Suppliers of Thiotepa backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- IDT AUSTRALIA LTD1 active DMF
- HERAEUS PRECIOUS METALS GMBH AND CO KG1 active DMF
- HERAEUS PRECIOUS METALS GMBH AND CO KG1 active DMF
- IDT AUSTRALIA LTD1 active DMF
- MSN Laboratories Private LimitedIndia1 active DMF
- Natco PharmaIndia1 active DMF
- SUMIKA FINE CHEMICALS CO LTD
- SOGO PHARMACEUTICAL CO LTD
- ICI COLOURS AND FINE CHEMS
- Jiangsu Hengrui Medicine Co., Ltd.China
- Taro Pharmaceutical Industries Ltd.Israel
- MYLAN LABORATORIES LTD
Patent & exclusivity (US)
Per the FDA Orange Book (18 approved US products), the latest listed US patent on Thiotepa expires 15 Aug 2041. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane
- Canonical SMILES
- C1CN1P(=S)(N2CC2)N3CC3
- InChIKey
- FOCVUCIESVLUNU-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.